Back to Screener

ZIMMER BIOMET HOLDINGS, INC. (ZBH)

NYSE Large Cap

Healthcare › Orthopedic, Prosthetic & Surgical Appliances & Supplies

$87.87
Market Cap: $17.2B
Data as of Sep 30, 2025 (TTM)

Price History

Feb 9, 2026 — Apr 4, 2026

Investment Snapshot

  • Trading 13% above Graham Number — above intrinsic value estimate
  • Piotroski F-Score 5/9 — moderate financial health
  • ROE of 6.4% — below-average profitability
  • Revenue growing at 7% annually

ZIMMER BIOMET HOLDINGS, INC. (ZBH) is a Healthcare company operating in Orthopedic, Prosthetic & Surgical Appliances & Supplies, listed on the NYSE , with a market capitalisation of $17.2 billion . Key value metrics: P/E ratio 21.1, P/B ratio 1.35, Piotroski F-Score 5 out of 9 (moderate financial health) .

Value Score

Key Metrics

P/E Ratio
21.10
1.35
EPS
$4.16
Div. Yield
1.1%
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio

Current vs 5-Year Average

Based on 5 years of SEC filings
Net Margin
↑ +2.1pp avg —
Gross Margin
↑ +2.1pp avg —
Operating Margin
↑ +2.1pp avg —
Return on Equity
↑ +2.1pp avg —
Debt / Equity
↑ +2.1pp avg —

Revenue & Net Income

EPS & Free Cash Flow Per Share

Financial Statements

Metric FY22 FY23 FY24
Revenue $X.XB $X.XB $X.XB
Gross Profit $X.XB $X.XB $X.XB
Operating Income $X.XB $X.XB $X.XB
Net Income $X.XB $X.XB $X.XB
EBITDA $X.XB $X.XB $X.XB
Total Assets $X.XB $X.XB $X.XB
Total Liabilities $X.XB $X.XB $X.XB
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

ZIMMER BIOMET HOLDINGS, INC. — Fundamental Analysis Summary

ZIMMER BIOMET HOLDINGS, INC. (ZBH) is currently trading 13% above its Graham Number of $77.98, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 21.1x.

On financial health, ZBH shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 6.4% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.55.

StockPik's composite Value Score for ZBH is 74/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

ZBH reports a high gross margin of 71.3% (sector average: 33.5%) and a solid operating margin of 15.7%.

ZBH shows revenue growing at 7% year-over-year, with earnings declining at 22%.

ZBH pays a modest dividend yield of 1.1%.

Top Value Stocks in Healthcare

Symbol Price P/E Score
CYRX $8.21 4.7 100
CRMD $6.70 3.6 100
CGEN $2.06 5.5 100
ABEO $4.82 4.5 100
BDMD $2.01 5.8 100
How is the Value Score calculated?
Read our full methodology →
How is the Graham Number calculated?
Benjamin Graham's intrinsic value formula, worked examples, and how to use it →
Previous
ZBAO
Next
ZBIO